drugset
drugset / Trial / NCT01444040

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

NCT01444040 ↗

Phase 4 Completed 196 enrolled Glaukos Corporation
RandomizedParallel-groupOpen-labelTreatment

Summary

Evaluation of the intraocular pressure (IOP) lowering effect of two iStent inject devices versus medical therapy in eyes of subjects with primary open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hypertension naïve to medical and surgical therapy.

Timeline

Start
2011-09
Primary completion
2019-03-28
Completion
2019-03-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Travoprost Other / unclassified 0.004 % Other

Indications

open-angle glaucoma